# Selective Plasma Adsorption of Extracellular DNA in Prevention of Intraoperative Metastasis in Pancreatic Cancer (Pilot Study)

> **NCT06967662** · NA · ENROLLING_BY_INVITATION · sponsor: **Ilyinskaya Hospital, JSC** · enrollment: 28 (estimated)

## Conditions studied

- Pancreatic Ductal Adenocarcinoma (PDAC)

## Interventions

- **PROCEDURE:** Selective plasma adsorption of extracellular DNA

## Key facts

- **NCT ID:** NCT06967662
- **Lead sponsor:** Ilyinskaya Hospital, JSC
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** ENROLLING_BY_INVITATION
- **Start date:** 2025-04-04
- **Primary completion:** 2027-04-04
- **Final completion:** 2027-04-04
- **Target enrollment:** 28 (ESTIMATED)
- **Last updated:** 2025-05-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06967662

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06967662, "Selective Plasma Adsorption of Extracellular DNA in Prevention of Intraoperative Metastasis in Pancreatic Cancer (Pilot Study)". Retrieved via AI Analytics 2026-07-15 from https://api.ai-analytics.org/clinical/NCT06967662. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*